Limbix
Mental Health CareCalifornia, United States2-10 Employees
Limbix develops prescription digital therapeutics that combine clinical expertise with digital design to expand access to mental health care for young people. Its offerings target adolescents and young adults, delivering a CBT-based neurobehavioral intervention with behavioral activation for depressive symptoms as an adjunct to conventional treatment. Based in Palo Alto, California, the company comprises a multidisciplinary team of clinicians, product designers, researchers, and engineers. In 2022, Limbix partnered with Children's Hospital Los Angeles to evaluate SparkRx, a digital therapeutic for adolescent depression.